Baclofen into the lateral parabrachial nucleus induces hypertonic sodium chloride intake during cell dehydration by unknown
Kimura et al. Behavioral and Brain Functions 2013, 9:17
http://www.behavioralandbrainfunctions.com/content/9/1/17RESEARCH Open AccessBaclofen into the lateral parabrachial nucleus
induces hypertonic sodium chloride intake during
cell dehydration
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Background: Activation of GABAB receptors with baclofen into the lateral parabrachial nucleus (LPBN) induces
ingestion of water and 0.3 M NaCl in fluid replete rats. However, up to now, no study has investigated the effects of
baclofen injected alone or combined with GABAB receptor antagonist into the LPBN on water and 0.3 M NaCl
intake in rats with increased plasma osmolarity (rats treated with an intragastric load of 2 M NaCl). Male Wistar rats
with stainless steel cannulas implanted bilaterally into the LPBN were used.
Results: In fluid replete rats, baclofen (0.5 nmol/0.2 μl), bilaterally injected into the LPBN, induced ingestion of
0.3 M NaCl (14.3 ± 4.1 vs. saline: 0.2 ± 0.2 ml/210 min) and water (7.1 ± 2.9 vs. saline: 0.6 ± 0.5 ml/210 min). In
cell-dehydrated rats, bilateral injections of baclofen (0.5 and 1.0 nmol/0.2 μl) into the LPBN induced an increase of
0.3 M NaCl intake (15.6 ± 5.7 and 21.5 ± 3.5 ml/210 min, respectively, vs. saline: 1.7 ± 0.8 ml/210 min) and an early
inhibition of water intake (3.5 ± 1.4 and 6.7 ± 2.1 ml/150 min, respectively, vs. saline: 9.2 ± 1.4 ml/150 min). The
pretreatment of the LPBN with 2-hydroxysaclofen (GABAB antagonist, 5 nmol/0.2 μl) potentiated the effect of
baclofen on 0.3 M NaCl intake in the first 90 min of test and did not modify the inhibition of water intake induced
by baclofen in cell-dehydrated rats. Baclofen injected into the LPBN did not affect blood pressure and heart rate.
Conclusions: Thus, injection of baclofen into the LPBN in cell-dehydrated rats induced ingestion of 0.3 M NaCl and
inhibition of water intake, suggesting that even in a hyperosmotic situation, the blockade of LPBN inhibitory
mechanisms with baclofen is enough to drive rats to drink hypertonic NaCl, an effect independent of changes in
blood pressure.
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The lateral parabrachial nucleus (LPBN), is a pontine
structure located dorsal to the superior cerebellar peduncle
(SCP). The LPBN is reciprocally connected to different
areas, such as area postrema (AP) and medial portion of
the nucleus of the solitary tract (mNTS) in the hindbrain
and forebrain areas, such as the paraventricular nucleus of
the hypothalamus, central nucleus of amygdala and me-
dian preoptic nucleus [1-7]. Cells in the LPBN are acti-
vated after ingestion of NaCl solutions by dehydrated rats
or by rats that received intragastric load of hypertonic* Correspondence: jocaller@foa.unesp.br
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reproduction in any medium, provided the orNaCl, suggesting that LPBN cells are activated by visceral
or taste signals [8-10]. Therefore, the LPBN may convey
signals that ascend from AP/mNTS to forebrain areas in-
volved in the control of fluid and electrolyte balance.
Studies about the involvement of the LPBN in the con-
trol of fluid-electrolyte balance have investigated mainly
the inhibitory mechanisms for water and NaCl intake
and different neurotransmitters or receptors in the LPBN
have been shown to be involved with these mechanisms.
For example, bilateral injection of the serotonergic an-
tagonist methysergide into the LPBN increased water
and 0.3 M NaCl intake induced by different treatments
[sodium depletion; subcutaneous treatment with the
combination of furosemide (FURO) + captopril (CAP)
and treatment with deoxycorticosterone (DOCA)], while
injections of a serotonergic agonist (DOI) reduced theseLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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intake is also produced by the blockade of cholecysto-
kinin (CCK) receptors or activation of GABAA and
GABAB receptors into the LPBN [14-16]. Therefore, in
the LPBN, neurotransmitters like serotonin (5-HT) and
CCK activate an inhibitory mechanism, while activation
of GABAergic receptors in the LPBN is suggested to
deactivate inhibitory mechanisms present in this area
increasing water and 0.3 M NaCl intake.
The LPBN is also related to the inhibition of sodium
intake by increased plasma osmolarity. Previous studies
have shown that the blockade of LPBN inhibitory mech-
anisms by injections of methysergide or moxonidine
combined with an increase in plasma osmolarity
(intragastric load of 2 M NaCl) induced an unexpected
ingestion of hypertonic NaCl [17,18], a clear paradox
considering that 2 M NaCl load usually suppresses so-
dium appetite [19]. In addition, a previous study showed
that activation of GABAA receptors into the LPBN in-
duced 0.3 M NaCl intake in cell-dehydrated rats,
suggesting that the increase in plasma osmolarity subse-
quent to NaCl ingestion does not appear to prevent fur-
ther salt intake when GABAA receptors in the LPBN are
activated [20].
The γ -aminobutyric acid (GABA) is the most import-
ant inhibitory neurotransmitter in the mammalian cen-
tral nervous system [21,22]. GABA receptors can be
classified into two structurally and pharmacologically
distinct subclasses: GABAA and GABAB [23,24]. Activa-
tion of GABAA receptors leads to opening of the chan-
nel and the conductance of Cl− ions and this effect may
be antagonized by bicuculline [25]. GABAB receptors are
metabotropic, G protein-coupled receptors that mediate
presynaptic and postsynaptic inhibition by reductions in
calcium conductance or increases in potassium conduct-
ance [24,26]. GABAB receptors are activated by baclofen
and 2-hydroxysaclofen antagonizes these receptors [26,27].
A dense plexus of GABA-immunoreactive varicosities
has been shown throughout the parabrachial nucleus
(PBN) and Kolliker fuse (KF) complex [28]. Both GABAA
and GABAB receptors are present in LPBN [29,30] and a
previous study showed that baclofen injected into LPBN
induced ingestion of 0.3 M NaCl and water in fluid replete
rats [31]. In addition, injections of baclofen into the
LPBN increased 0.3 M NaCl and water intake by rats
injected subcutaneously with the diuretic furosemide
combined with the angiotensin converting enzyme in-
hibitor captopril [16].
Considering the possibility that baclofen deactivates
the inhibitory mechanisms and increases 0.3 M NaCl in-
take in cell-dehydrated rats like that produced by
GABAA receptor activation in the LPBN, in the present
study, we investigated the effects of bilateral injections
of baclofen alone or combined with the GABAB receptorantagonist 2-hydroxysaclofen into the LPBN on 0.3 M
NaCl and water intake in rats with increased plasma
osmolarity and compared the responses with the effects
of baclofen into the LPBN on sodium intake in fluid re-
plete rats that received no pre-treatment. In addition,
possible changes in cardiovascular responses to baclofen
injected into the LPBN in cell-dehydrated rats were also
investigated. Intragastric load of 2 M NaCl produces cell
dehydration by increasing plasma osmolality and sodium
concentration and also reduces plasma renin activity [32].
Materials and methods
Animals
Male Wistar rats weighing 290–310 g were used. The
animals were housed in individual stainless steel cages
with free access to normal sodium diet (Guabi Rat
Chow, Paulinia, SP, Brazil), water and 0.3 M NaCl solu-
tion. The position of the bottles containing water and
0.3 M NaCl was rotated daily to avoid place preference.
Room temperature was maintained at 23 ± 2°C and hu-
midity at 55 ± 10% in a 12:12 light–dark cycle with light
onset at 07:30 AM. The Institutional Ethics Committee
on Animal Care and Use of the School of Dentistry,
Araçatuba–UNESP approved the experimental protocols
used in the present study (Proc. CEEA No. 057/03) and
followed the recommendations of the Brazilian College
of Animal Experimentation (COBEA). The procedures
were in compliance with the National Institutes of
Health Guide for the Care and Use of Laboratory Ani-
mals (NIH publication No. 80–23, 1996, USA). All ef-
forts were made to minimize animal discomfort and the
number of animals used.
Cerebral cannulas
Rats were anesthetized with ketamine (80 mg/kg of body
weight, Agener União, Embu-Guaçu, SP, Brazil) com-
bined with xylazine (7 mg/kg of body weight, Agener
União, Embu-Guaçu, SP, Brazil ) and placed in a Kopf
stereotaxic instrument (Kopf, Tujunga, CA, USA). The
skull was leveled between bregma and lambda. Bilateral
stainless steel 23-gauge cannulas were implanted in dir-
ection to the LPBN using the following coordinates: 9.4
mm caudal to bregma, 2.2 mm lateral to the midline,
and 3.9 mm below the dura mater. The tips of the can-
nulas were put into place at a point 2 mm above each
LPBN. The cannulas were fixed to the cranium using
dental acrylic resin and jeweler screws. A 30-gauge metal
obturator filled the cannulas between tests. The experi-
ments began 5 days later when the animals had fully re-
covered from the surgery.
Injections into the LPBN
Bilateral injections into the LPBN were made using 5-μl
Hamilton syringe connected by polyethylene tubing (PE-
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the obturators were removed and the injection cannula
(2 mm longer than the guide cannula) was carefully
inserted into the guide cannula, and manual injection was
initiated 15 s later. For bilateral injections, the first injection
was initially performed in one side, the needle was with-
drawn and repositioned on the contralateral side, and then
the second injection was made. Therefore, injections were
made ~1 min apart. The injection volume into the LPBN
was 0.2 μl in each site. The obturators were replaced after
the injections, and the rats were put back into their cages.
Drugs
The drugs injected into the LPBN were (±)-baclofen and
2-hydroxysaclofen purchased from Sigma-Aldrich (Saint
Louis, MO, USA) and were dissolved in 0.15 M NaCl. The
doses of baclofen and 2-hydroxysaclofen were chosen
based on a previous study [31]. Doses of baclofen produce
a long-lasting action (at least for three hours) when
injected into the LPBN. The dose of 2-hydroxysaclofen
used was an effective dose that blocks GABAB receptors
into LPBN as showed previously [31].
Water and 0.3 M NaCl intake
The rats were tested in their home cages. In addition to
water and food pellets, rats had access to 0.3 M NaCl
for at least 5 days before the experiments began. The ef-
fects of baclofen were tested under three different ex-
perimental conditions: 1) In the same group of rats
(n=9), we evaluated if baclofen affect water and 0.3 M
NaCl intake in rats that received no pre-treatment (fluid
replete rats) and after intragastric load of 2 M NaCl
(cell-dehydrated condition). First, fluid replete rats re-
ceived injections of baclofen (0.5 nmol/0.2 μl) or saline
into the LPBN and 15 min later rats were given water
and 0.3 M NaCl in graduated (0.1 ml divisions) glass bu-
rettes. Cumulative water and 0.3 M NaCl intake was
measured at each 30 min time interval in the next 210
min after the access to water and sodium solution. The
same group of animals, received an intragastric load of 2
M NaCl, to induce cellular dehydration. Forty-five mi-
nutes later, half of the group received injections of baclo-
fen (0.5 nmol/0.2 μl), and the other half received saline
into the LPBN and 15 min later rats had free access to
both water and 0.3 M NaCl (two-bottle test). Cumulative
water and 0.3 M NaCl intake was recorded at each 30
min time interval in the next 210 min after the access to
water and sodium solution. The same procedure was re-
peated in a second experimental session performed 3
days later in a counterbalanced design. All tests began
between 13:00 p.m. and 16:00 p.m.
2) In another group of cell-dehydrated rats (n=11), the
effects of two different doses of baclofen (0.5 and 1.0
nmol/0.2 μl) injected into the LPBN on water and 0.3 MNaCl intake were tested. Rats received an intragastric load
of 2 M NaCl. Forty-five minutes later, half of the group re-
ceived baclofen (0.5 or 1.0 nmol/0.2 μl), and the other half
received saline injections into the LPBN. The same pro-
cedure was repeated in a second experimental session
performed 3 days later in a counterbalanced design. Fifteen
minutes after LPBN injections, the animals had free ac-
cess to both water and 0.3 M NaCl. Cumulative water
and 0.3 M NaCl intake was recorded at each 30, 60, 90,
120, 180, and 210 min after the access to water and sodium
solution. All tests began between 13:00 p.m. and 16:00 p.m.
3) To test a possible participation of GABAB receptors
in the effects of baclofen, another group of rats (n=6) re-
ceived an intragastric load of 2 M NaCl 45 min before
bilateral injections of baclofen (0.5 nmol/0.2 μl) or saline
into the LPBN, and cumulative water and 0.3 M NaCl
intake was measured at each 30 min in the next 210
min, starting 15 min after the injections of baclofen or
saline into the LPBN. This group of rats also received bi-
lateral injections of 2-hydroxysaclofen (5 nmol/0.2 μl) or
saline into the LPBN, 15 min before baclofen or saline
injections. This group of rats was submitted to four tests.
In each test the group was divided in two subgroups that
received different combinations of treatments into the
LPBN. The sequence of the combinations of treatments
into the LPBN in each rat in different tests was random-
ized, and at the end of the tests each rat received all the
combinations of treatments into the LPBN. All tests
began between 13:00 p.m. and 16:00 p.m.Arterial pressure and heart rate recordings
Mean arterial pressure (MAP) and heart rate (HR) were
recorded in unanesthetized rats. One day before record-
ing, the rats were anesthetized with ketamine (80 mg/kg
of body weight) + xylazine (7 mg/kg of body weight), a
polyethylene tubing (PE 10 connected to a PE 50) was
inserted into the abdominal aorta through the femoral
artery for arterial pressure recording. The cannula was
guided subcutaneously and exteriorized at the back of
the rat. On the next day, the cannula was connected to a
P23 Db pressure transducer (Statham Gould) coupled to
a pre-amplifier (model ETH-200 Bridge Bio Amplifier,
CB Sciences) connected to a Powerlab computer record-
ing system (Powerlab 8SP, ADInstruments) to record
MAP and HR. The animals received an intragastric 2 M
NaCl load and forty-five minutes after this, one group of
rats was tested for the effects of baclofen (1.0 nmol/0.2
μl) and another group for the effects of saline injected
into the LPBN on MAP and HR. MAP and HR were
recorded for the next 180 minutes after injections into
LPBN and the maximum changes were analyzed. During
MAP and HR recordings, the rats did not have access to
water, 0.3 M NaCl and food.
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On completion of the experiments, the animals received
bilateral injections of 0.2 μl of 2% Evans blue dye into the
LPBN. Then, they were deeply anesthetized with sodium
thiopental (80 mg/kg of body weight) and perfused
transcardially with saline followed by 10% formalin. The
brains were removed, fixed in 10% formalin, frozen, cut in
60 μm serial coronal sections, stained with Giemsa, and
analyzed by light microscopy to confirm the injection sites
into the LPBN.Statistical analysis
The results are reported as means ± S.E.M. Water and
0.3 M NaCl intake were analyzed by two-way analysis of
variance (ANOVA) with repeated measures for both fac-
tors (treatments and times), followed by Newman-Keuls
post hoc test. Significance was set at P < 0.05. The soft-
ware used to analyze the data was SigmaStat for Win-
dows, version 2.03 from SPSS Inc.Results
Histological analysis
Similar to previous reports [16,20,31], the LPBN injection
sites were centered in the central lateral and dorsolateral
portions of the LPBN. Figure 1 shows the typical LPBN in-
jection sites. Injections reaching the ventral lateral and ex-
ternal lateral portions, as well as the Kolliker-Fuse
nucleus, were observed in some rats and the results from
these rats were included in the analysis. In some rats, in-
jections also spread to the brachium (superior cerebellar
peduncle), or slightly ventral to this structure, reaching
the dorsal portions of the medial parabrachial nucleus
(MPBN) uni- or bilaterally. There was no difference in the
effects whether injections were restricted to the LPBN or
also spread to brachium and dorsal portions of MPBN.Figure 1 Photomicrograph showing the sites of injections into
the LPBN (arrows).Effects of bilateral injections of baclofen into the LPBN on
water and 0.3 M NaCl intake in fluid replete and cell-
dehydrated rats
Bilateral injection of baclofen (0.5 nmol/0.2 μl, n=9) into
the LPBN in fluid replete rats induced 0.3 M NaCl and
water intake from 150 to 210 min of test (Figure 2A, C).
In rats treated with an intragastric load of 2 M NaCl, baclo-
fen injected into the LPBN increased 0.3 M NaCl intake
from 150 to 210 min of test (Figure 2A, B) and reduced
water intake from 30 to 150 min of test (Figure 2C, D).
ANOVA showed significant interaction between treatments
and time for 0.3 M NaCl intake [F(18, 144) = 4.3; P < 0.001,
Figure 2A, B] and water intake [F(18, 144) = 3.3; P < 0.001,
Figure 2C, D) in fluid replete rats and cell-dehydrated rats
that received baclofen into the LPBN.
A hypotonic mixture of water and 0.3 M NaCl was
ingested throughout the experimental session when fluid
replete rats received saline in the LPBN. On an average,
the rats ingested 0.2 ± 0.2 ml of 0.3 M NaCl versus 0.6 ±
0.5 ml of water in 210 min, which yielded a solution of
approximately 0.09 M. However, fluid replete rats that re-
ceived baclofen into the LPBN ingested 14.3 ± 4.1 ml of
0.3 M NaCl and 7.1 ± 2.9 ml of water in 210 min, which
results in a hypertonic solution (0.2 M) (Figure 2A, C).
After intragastric load of 2 M NaCl, bilateral LPBN in-
jections of baclofen (0.5 and 1.0 nmol/0.2 μl) into the
LPBN induced ingestion of 0.3 M NaCl from 120 to 210
min of test (Figure 3A, B), and an inhibition of water in-
take from 30 to 120 min of test (Figure 3C, D). There
were no significant differences in 0.3 M NaCl intake
[F(1,10) = 1.1; P > 0.05, Figure 3A, B] and water in-
take [F(1,10) = 2.8; P > 0.05, Figure 3C, D], in cell-
dehydrated rats treated with different doses of baclo-
fen (0.5 and 1.0 nmol/0.2 μl) into the LPBN.
Cell-dehydrated rats (n=11) that received saline in the
LPBN ingested 1.7 ± 0.8 ml of 0.3 M NaCl and 9.2 ± 1.4
ml of water in 210 min. Considering the total intake, the
result is a hypotonic solution (nearly 0.05 M). Cell-
dehydrated rats treated with baclofen (0.5 nmol/0.2 μl)
into the LPBN ingested 17.9 ± 4.2 ml of 0.3 M NaCl and
5.2 ± 1.9 ml of water in 210 min, which results in a
hypertonic solution (nearly 0.23 M). Cell-dehydrated rats
treated with baclofen (1.0 nmol/0.2 μl) into the LPBN
also ingested a hypertonic solution (0.21 M).Effects of the combination of 2-hydroxysaclofen and
baclofen into the LPBN on water and 0.3 M NaCl intake in
cell-dehydrated rats
ANOVA showed significant differences among treatments
for 0.3 M NaCl intake by cell-dehydrated rats that received
saline or 2-hydroxysaclofen combined with saline or baclo-
fen into the LPBN [F(3, 15) = 9.5; P < 0.05, Figure 4A, B].
There was significant interaction between treatments
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Figure 2 (A,C) Cumulative and (B,D) individual 0.3 M NaCl and water intake in fluid replete rats and in rats treated with i.g. 2 M NaCl
load combined with injections of baclofen or saline into the LPBN. (A and C) Values are means ± S.E.M. n = Number of rats. * different from
saline; + different from 2 M NaCl + saline. Fewer symbols appear in B and D because of overlapping data.
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Figure 3 (A,C) Cumulative and (B, D) individual 0.3 M NaCl and water intake in rats treated with i.g. 2 M NaCl load combined with
injections of baclofen or saline into the LPBN. (A and C) Values are means ± S.E.M. n = Number of rats. * different from 2 M NaCl + saline.
Fewer symbols appear in B and D because of overlapping data.
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Figure 4C, D].
Bilateral injections of baclofen after pretreatment with sa-
line into the LPBN induced 0.3 M NaCl intake from 150 to
210 min of the test with P values ranging from P < 0.005 at
150 min to P < 0.001 at 180 and 210 min (Figure 4A). Bac-
lofen induced an early inhibitory effect on water intake in
the first 150 min of the test with P values ranging from
P < 0.05 at 30 min to P < 0.001 at 60 to 150 min
(Figure 4C, D). Previous injections of 2-hydroxysaclofen
(5 nmol/0.2 μl) into the LPBN increased 0.3 M NaCl intake
induced by baclofen in the first 90 minutes of test (8.6 ± 3.6;
12.0 ± 4.3 vs, baclofen: 0.01 ± 0.01; 1.7 ± 0.7 ml; respectively
for 60 and 90 min; P < 0.005, Figure 4A), and did not
modify 0.3 M NaCl intake induced by baclofen injected in
the same area from 120 to 210 min of test (P > 0.1).
Water intake after 2-hydroxysaclofen + baclofen into the
LPBN did not differ from saline + baclofen into the LPBN
(P > 0.5 for all times tested, Figure 4C, D). After saline +
2-hydroxysaclofen injection into the LPBN, water or 0.3 M
NaCl intake did not differ from control test with saline in-
jections into the LPBN (P > 0.1 at any of the times studied).
Effects of bilateral injections of baclofen into the LPBN on
arterial pressure and HR in cell-dehydrated rats
Bilateral injections of baclofen (1 nmol/0.2 μl) into the
LPBN in normotensive rats (basal MAP: 120 ± 4.2Time (min)
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Figure 4 (A,C) Cumulative and (B,D) individual 0.3 M NaCl and water in
2-hydroxysaclofen or saline combined with baclofen or saline into the L
* different from saline + saline; + different from saline + baclofen. Fewer symmHg and basal HR: 363 ± 6.6 beats per min, bpm),
previously treated with intragastric load of 2 M NaCl,
did not affect changes in MAP (3.7 ± 3.8 vs. saline: 4.9 ±
1.5 mmHg, n=7), [F (1, 6) = 0.1; P > 0.05] neither
changes in HR (1.5 ± 12.7 vs. saline: 6.7 ± 13.7 bpm),
[F (1, 6) = 0.5; P > 0.05].Specificity of injections into the LPBN to produce the
effects on water and 0.3 M NaCl intake in cell-dehydrated
rats
The specificity of the LPBN as the site where baclofen
produced the effects on water and 0.3 M NaCl intake in
cell-dehydrated rats was confirmed by results from rats in
which the injections did not reach the LPBN (misplaced
injections). Bilateral injections of baclofen (0.5 nmol),
2-hydroxysaclofen (5 nmol) or 2-hydroxysaclofen com-
bined with baclofen outside the LPBN produced no
effect on 0.3 M NaCl or on water intake (Table 1).
ANOVA showed no significant difference among treat-
ments for 0.3 M NaCl intake [F(3, 15) = 0.54; P > 0.05]
or water intake [F(3, 15) = 1.69; P > 0.05] by cell-
dehydrated rats that received injections in sites outside
the LPBN (Table 1). Injections outside the LPBN
reached different sites; the majority were dorsal or
caudal to the LPBN, although a few were ventral or















































take in rats treated with i.g. 2 M NaCl load followed by injections of
PBN. (A and C) Values are means ± S.E.M. n = Number of rats.
mbols appear in B and D because of overlapping data.
Table 1 Ingestion of water and 0.3 M NaCl by cell-
dehydrated rats treated with saline or 2-hydroxysaclofen
combined with saline or baclofen in sites outside the
LPBN (misplaced injections)
Treatments n 0.3 M NaCl intake Water intake
(ml/210 min) (ml/210 min)
Saline + saline 6 2.8±1.3 8.9±1.4
Saline + baclofen (0.5 nmol) 6 3.1±1.7 6.5±2.8
2-hydroxysaclofen (5 nmol) +
baclofen 6 3.9±1.8 7.9±2.8
2-hydroxysaclofen (5 nmol) +
saline 6 3.6±2.3 8.3±2.2
Values are means ± S.E.M.; n, number of rats.
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In the present study, we showed that bilateral injections
of baclofen into the LPBN induced both 0.3 M NaCl and
water intake in rats that received no pre-treatment. Bi-
lateral injections of baclofen into the LPBN induced in-
gestion of 0.3 M NaCl (from 120 to 210 min of test) and
inhibited the large increases in water intake in
hyperosmotic cell-dehydrated rats. At the end of 210
min of test, fluid replete rats and cell-dehydrated rats
ingested a similar amount of 0.3 M NaCl after adminis-
tration of baclofen into the LPBN despite of the
hyperosmolality, hypernatremia, reduction of plasma
renin activity and normovolemia present in cell-
dehydrated rats [32]. Results from rats with misplaced
injections confirmed that baclofen produces effects on
water and 0.3 M NaCl intake if injected specifically in
the LPBN and not into the surrounding areas.
In a recent study [20], the authors also showed that
the blockade of LPBN inhibitory mechanisms by injec-
tions of muscimol in this area also induced 0.3 M NaCl
intake in fluid replete rats and in rats treated with
intragastric 2 M NaCl load, suggesting that the increase
in plasma osmolarity subsequent to NaCl ingestion does
not appear to prevent further salt intake when GABAA
receptors in the LPBN are activated.
Therefore, the present results suggest that baclofen
injected into the LPBN induces ingestion of 0.3 M NaCl
irrespective of the initial physiological state of the rats.
A possible conclusion from these results is that it is not
necessary to activate the excitatory mechanisms by bac-
lofen into the LPBN for NaCl intake, which differs from
the mechanisms that have been proposed to explain in-
creased sodium intake after the blockade of LPBN in-
hibitory mechanisms [11-13].
Peripheral administration of baclofen reduce water
deprivation-induced water intake and reduce water in-
take in rats pretreated with a hypertonic solution of
NaCl [33,34]. The results obtained in this study on the
effects of baclofen injected into the LPBN on waterintake in dehydrated rats are therefore similar to those
previously reported [33]. Ebenezer et al. [34] also dem-
onstrated that systemic administration of baclofen had
no effects on water intake in fluid replete rats. Interest-
ingly, in the present study was demonstrated that bilat-
eral injection of baclofen into the LPBN induced water
and 0.3 M NaCl intake (150 – 210 min of test) in a two-
bottle test in fluid replete rats. Recently [31], we showed
that injections of baclofen into the LPBN induced no
water intake if only water was available. As indicated by
the present results, ingestion of water usually increased
after injections of baclofen into the LPBN when fluid re-
plete rats simultaneously ingested 0.3 M NaCl. In spite
of the simultaneous ingestion of water, this intake is not
enough to compensate for the increased osmolarity pro-
duced by the ingestion of hypertonic NaCl. The fluid
ingested (water and 0.3 M NaCl), after injections of bac-
lofen into the LPBN, was hypertonic during most of the
test. Therefore, it seems that the increase in plasma
osmolarity due to the ingestion of hypertonic NaCl may
be reinforcing the effect of baclofen on sodium intake
instead of inducing water intake.
We suggest that the effect of baclofen injected into the
LPBN on water and sodium intake was due to a direct
effect of baclofen on the LPBN. Callera et al. [15] dem-
onstrated that bicuculline injected into the LPBN 60
min after muscimol strongly reduced the effects of mus-
cimol on 0.3 M NaCl and water intake, suggesting that
muscimol and probably baclofen is acting at this mo-
ment releasing water and sodium intake. On the con-
trary, baclofen into the LPBN reduced water intake in
cell-dehydrated rats (30–150 min of test). Therefore, the
effects on 0.3 M NaCl and water intake were due to bac-
lofen facilitating the actions on GABA receptors.
The natriorexigenic effect of baclofen might be a sec-
ondary effect of baclofen injected into the LPBN, and re-
ductions in blood pressure or increases in renal
excretion would be one possibility. However, baclofen
injected into the LPBN produces non-significant effects
on blood pressure and renal excretion in fluid replete
rats and cell-dehydrated rats [31, present data],
suggesting that the natriorexigenic response to baclofen
injected into the LPBN is not secondary to cardiovascu-
lar responses or increased renal excretion. It seems that
injections of baclofen, similar to the injections of musci-
mol into the LPBN [20], completely block the action of
all the inhibitory mechanisms present in the LPBN,
which combined with any residual facilitatory signal still
present as the one produced by normal levels of ANG II
may facilitate water and especially NaCl intake.
Recently [16], we showed that pretreatment of the
LPBN with bilateral injections of the nonpeptide AT1 re-
ceptor antagonist losartan reduced 0.3 M NaCl and
water intake caused by baclofen injected into the same
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and 0.3 M NaCl produced by baclofen injected bilaterally
into the LPBN in FURO+CAP-treated rats, suggesting
that angiotensinergic mechanisms in the LPBN are es-
sential for the dipsogenic and natriorexigenic responses
induced by the blockade of LPBN neurons with baclofen
in fluid replete rats or FURO+CAP-treated rats. It is
possible that ANG II acting on AT1 receptors in
hyperosmotic cell-dehydrated rats is not sufficient to
facilitate water intake produced by baclofen in the
LPBN. The ingestion of 0.3 M NaCl after baclofen in-
jections into the LPBN takes at least 2 h to start,
which is a time enough for changes in the levels of
ANG II that acting in the LPBN may intensify the ef-
fects of baclofen on LPBN neurons, a step necessary
for the release of sodium intake. More studies are ne-
cessary to investigate the effects of previous injection
of AT1 receptor antagonist on water and sodium in-
take induced by baclofen injected into the LPBN in
hyperosmotic cell-dehydrated rats.
The present study also showed that blockade of the
GABAB receptors with 2-hydroxysaclofen alone into the
LPBN did not affect sodium intake in cell-dehydrated
rats, suggesting that GABAergic mechanisms in the
LPBN do not tonically inhibit or facilitate 0.3 M NaCl
intake [15,20,31]. In addition, previous blockade of the
GABAB receptors with 2-hydroxysaclofen injected into
the LPBN produced no effect on late 0.3 M NaCl intake
and inhibition of water intake induced by baclofen
injected in the same area. Although still not completely
clear, the blockade of GABAB receptor potentiated the
natriorexigenic effect of baclofen in the first 90 min of
the test. An involvement of GABAA and GABAB recep-
tors in the natriorexigenic effect of baclofen has previ-
ously been reported [31]. The natriorexigenic effect of
baclofen injected into the LPBN in fluid replete rats was
reduced by the pre-treatment with the GABAB receptor
antagonist 2-hydroxysaclofen or by the GABAA receptor
antagonist bicuculline injected into the same area. Per-
haps, the activation of GABAB receptors by baclofen
injected into the LPBN together with a baseline activa-
tion of GABAA receptors by endogenous GABA pro-
duces a sufficient inhibition of LPBN mechanisms to
release sodium intake. Or instead of endogenous GABA,
a nonspecific activation of a limited number of GABAA
receptors by baclofen together with the activation of
GABAB receptors in the LPBN might inhibit the LPBN
mechanisms releasing NaCl intake. In both cases, al-
though only the activation of GABAB receptors produces
no sodium intake, the activation of GABAB receptors in
the LPBN may facilitate the effects of GABAA receptor
activation on sodium intake. An involvement of GABAA
receptors on baclofen effects was already reported. The in-
hibition of food intake by intraperitoneal administration ofbaclofen was abolished by previous treatment with
bicuculline, suggesting a possible involvement of GABAA
receptors in the effects of baclofen [35].
Thus, the present results show that the blockade of
LPBN mechanisms with baclofen induces hypertonic
NaCl intake and reduces water intake in cell-dehydrated
rats and induces hypertonic NaCl intake and reduces
urinary sodium excretion and diuresis in fluid replete
rats [31], all responses consistent with an action of
LPBN mechanisms against body fluid volume expansion
as previously proposed for the serotonergic mechanism
in the LPBN [36]. Thus, further studies in rats submitted
to intracellular dehydration are needed to test the effects
of GABA receptors of the LPBN on behavioral and renal
functions that induce to volume expansion.
Conclusion
In conclusion, the results of our experiments show that
fluid replete rats or hyperosmotic cell-dehydrated rats
ingest similar amounts of 0.3 M NaCl after bilateral in-
jections of baclofen into the LPBN. This observation
means that, after the blockade of LPBN inhibitory mech-
anisms with baclofen, hypertonic NaCl intake occurs in-
dependent of whether plasma renin levels are normal or
reduced and independent of changes in blood pressure.
Abbreviations
(ANG II): Angiotensin II; (AP): Area postrema; (bpm): Beats per minute;
(b. wt.): Body weight; (CAP): Captopril; (CCK): Cholecystokinin;
(CRF): Corticotrophin release factor; (DOCA): Deoxycorticosterone acetate;
(DOI): 2,5-dimetoxy-4-iodoamphetamine hydrobromide; (FURO): Furosemide;
(GABA): Gamma-aminobutyric acid; (HR): Heart rate; (i.g.): Intragastric;
(LPBN): Lateral parabrachial nucleus; (MAP): Mean arterial pressure;
(NaCl): Sodium chloride; (OVLT): Organum vasculosum of the lamina
terminalis; (SCP): Superior cerebellar peduncle.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
All the authors have made a substantial contribution to the conception and
design of the study (EHK, LBO, JVM and JCC), the acquisition, analysis and
interpretation of the data (EHK and JCC) and the drafting and revision of the
article (LBO, JVM, and JCC). All the authors read and approved the final
manuscript.
Acknowledgements
The authors thank Arnaldo Cesar dos Santos for animal care. This research
was supported by Brazilian public funding from Sao Paulo State Research
Foundation (FAPESP) and Fundação para o Desenvolvimento da UNESP
(FUNDUNESP). Everton H. Kimura was recipient of graduate fellowships from
FAPESP (São Paulo State Research Foundation, grant 2003/10592-0).
Author details
1Department of Basic Sciences, School of Dentistry, UNESP – Univ. Estadual
Paulista, Rodovia Marechal Rondom, km 527, Araçatuba, São Paulo
16018-805, Brazil. 2Department of Biological Sciences, DECBI-NUPEB, Federal
University of Ouro Preto, UFOP, Ouro Preto, Minas Gerais, Brazil. 3Department
of Physiology and Pathology, School of Dentistry, UNESP, Araraquara, São
Paulo, Brazil.
Received: 7 December 2012 Accepted: 23 April 2013
Published: 3 May 2013
Kimura et al. Behavioral and Brain Functions 2013, 9:17 Page 9 of 9
http://www.behavioralandbrainfunctions.com/content/9/1/17References
1. Norgren R: The central organization of the gustatory and visceral
systems in the nucleus of the solitary tract. In Brain Mechanisms of
Sensation. Edited by Katsuki Y, Norgren R, Sato M. New York: Wiley;
1981:143–160.
2. Ciriello J, Laurence D, Pittman QJ: Electrophysiological identification of
neurons in the parabrachial nucleus projecting directly to the
hypothalamus in the rat. Brain Res 1984, 322:388–392.
3. Fulwiler CE, Saper CB: Subnuclear organization of the efferent
connections of the parabrachial nucleus in the rat. Brain Res Rev 1984,
7:229–259.
4. Shapiro RE, Miselis RR: The central neural connections of the area
postrema of the rat. J Comp Neurol 1985, 234:344–364.
5. Herbert H, Moga MM, Saper CB: Connections of the parabrachial nucleus
to the solitary tract and the medullary reticular formation in the rat.
J Comp Neurol 1990, 293:540–580.
6. Jhamandas JH, Petrov T, Harris KH, Vu T, Krukoff TL: Parabrachial nucleus
projection to the amygdala in the rat: electrophysiological and
anatomical observations. Brain Res Bull 1996, 39:115–126.
7. Krukoff TL, Harris KH, Jhamandas JH: Efferent projections from the
parabrachial nucleus demonstrated with the anterograde tracer
Phaseolus vulgaris leucoaglutinin. Brain Res Bull 1993, 30:163–172.
8. Kobashi M, Ichikawa H, Sugimoto T, Adachi A: Response of neurons in the
solitary tract nucleus, area postrema and lateral parabrachial nucleus to
gastric load of hypertonic saline. Neurosci Lett 1993, 158:47–50.
9. Yamamoto T, Shimura T, Sako N, Sakai N, Tanimizu T, Wakisaka S: cFos
expression in the parabrachial nucleus after ingestion of sodium
chloride in the rat. Neuroreport 1993, 4:1223–1226.
10. Franchini LF, Vivas L: Distribution of Fos immunoreactivity in rat brain
after sodium comsumption induced by peritoneal dialysis. Am J Physiol
1999, 276:R1180–R1187.
11. Menani JV, Thunhorst RL, Johnson AK: Lateral parabrachial nucleus and
serotonergic mechanisms in the control of salt appetite in rats. Am J
Physiol 1996, 270:R162–R168.
12. Menani JV, De Luca LA Jr, Johnson AK: Lateral parabrachial nucleus
serotonergic mechanisms and salt appetite induced by sodium
depletion. Am J Physiol 1998, 274:R555–R560.
13. De Gobbi JIF, De Luca LA Jr, Menani JV: Serotonergic mechanisms of the
lateral parabrachial nucleus on DOCA-induced sodium intake. Brain Res
2000, 880:131–138.
14. De Gobbi JIF, De Luca LA Jr, Johnson AK, Menani JV: Interaction of
serotonin and cholecystokinin in the lateral parabrachial nucleus to
control sodium intake. Am J Physiol 2001, 280:R1301–R1307.
15. Callera JC, De Oliveira LB, Barbosa SP, Colombari DAS, De Luca Jr LA, Menani JV:
GABAA receptor activation in the lateral parabrachial nucleus induces water
and hypertonic NaCl intake. Neuroscience 2005, 134:725–735.
16. Da Silva CZC, Menani JV, Callera JC: Natriorexigenic effect of baclofen is
reduced by AT1 receptor blockade in the lateral parabrachial nucleus.
Brain Res Bull 2011, 86:348–354.
17. De Luca Jr LA, Barbosa SP, Menani JV: Brain serotonin blockade and
paradoxical salt intake in rats. Neuroscience 2003, 121:1055–1061.
18. Andrade CAF, De Luca LA Jr, Colombari DSA, Menani JV: Alpha2-adrenergic
activation in the lateral parabrachial nucleus induces NaCl intake under
conditions of systemic hyperosmolarity. Neuroscience 2006, 142:21–28.
19. Blackburn RE, Samson WK, Fulton RJ, Stricker EM, Verbalis JG: Central
oxytocin and ANP receptors mediate osmotic inhibition of salt appetite
in rats. Am J Physiol 1995, 269:R245–R251.
20. Kimura EH, De Oliveira LB, Colombari DSA, De Luca LA Jr, Menani JV, Callera
JC: Sodium intake by hyperosmotic rats treated with a GABAA receptor
agonist into the lateral parabrachial nucleus. Brain Res 2008, 1190:86–93.
21. Sivilotti L, Nistri A: GABA receptor mechanism in the central nervous
system. Prog Neurobiol 1991, 36:35–92.
22. Araki T, Kiyama H, Tohyama M: The GABAA receptor gamma 1 subunit is
expressed by distinct neuronal populations. Mol Brain Res 1992, 15:121–132.
23. Bowery NG, Hudson AL, Price GW: GABAA and GABAB receptor site distribution
in the rat central nervous system. Neuroscience 1987, 20:365–383.
24. Bowery NG: GABAB receptors and their significance in mammalian
pharmacology. Trends Pharmacol Sci 1989, 10:401–407.
25. Akaiki N, Hattori K, Oomura Y, Carpenter DO: Bicuculline and picrotoxinin
block γ–aminobutyric acid-gated Cl- conductance by different
mechanisms. Experientia 1985, 41:70–71.26. Kerr DIB, Ong J: GABAB receptors. J Pharmacol Ther 1995, 67:187–246.
27. Kerr DIB, Ong J, Johnston GAR, Abbenante J, Prager RH: 2-Hydroxy-
saclofen: an improved antagonist at central and peripheral GABAB
receptors. Neurosci Lett 1988, 92:92–96.
28. Guthmann A, Fritschy JM, Ottersen OP, Torp R, Herbert H: GABA, GABA
transporters, GABA(A) receptor subunits, and GAD mRNAs in the rat
parabrachial and kolliker-Fuse nuclei. J Comp Neurol 1998, 19:229–243.
29. Christie MJ, North RA: Agonists at mu-opioid, M2-muscarinic and GABAB
receptors increase the same potassium conductance in rat lateral
parabrachial neurones. Br J Pharmacol 1988, 95:896–902.
30. Van Nieuwenhuijzen PS, Mcgregor IS, Hunt GE: The distribution of γ–
hydroxybutyrate-induced Fos expression in rat brain: Comparison with
baclofen. Neuroscience 2009, 158:441–455.
31. De Oliveira LB, Kimura EH, Callera JC, De Luca LA Jr, Colombari DSA, Menani
JV: Baclofen into the lateral parabrachial nucleus induces hypertonic
NaCl and sucrose intake in rats. Neuroscience 2011, 183:160–170.
32. Pereira DT, Vendramini RC, David RB, Nozaki PN, Menani JV, De Luca LA Jr:
Isotonic NaCl intake by cell-dehydrated rats. Physiol Behav 2002, 76:501–505.
33. Houston AJ, Wong JCL, Ebenezer IS: Effects of the GABAB receptor agonist
baclofen on primary drinking in rats. Eur J Pharmacol 2012, 674:327–331.
34. Ebenezer IS, Houston AJ, Crook TJ: Systemic administration of baclofen
inhibits water intake in rats. Gen Pharmacol 1992, 23:375–379.
35. Zarrindast MR, Hosseini-Nia T, Allah-Maddadi S: Food intake suppressant
effect of baclofen in rats. Gen Pharmacol 1989, 20:701–703.
36. Margatho LO, Giusti-Paiva A, Menani J, Elias LLK, Vivas LM, Antunes-
Rodrigues J: Serotonergic mechanisms of the lateral parabrachial nucleus
in renal and hormonal responses to isotonic blood volume expansion.
Am J Physiol 2007, 292:R1190–R1197.
doi:10.1186/1744-9081-9-17
Cite this article as: Kimura et al.: Baclofen into the lateral parabrachial
nucleus induces hypertonic sodium chloride intake during cell
dehydration. Behavioral and Brain Functions 2013 9:17.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
